Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04420793 · ClinicalTrials.gov registry record
Voice Changes During ECT
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 11
- Enrollment target
NCT04420793: Completed study, sponsored by Medical University of South Carolina.
NCT04420793 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04420793 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
Depressed patients talk differently when they are depressed compared to when they are well. But it is hard to actually measure what the differences are. The study team will record voice samples from patients with mood disturbances, like depression, over the course of their receiving an electroconvulsive therapy (ECT) series. The study team will try and measure or quantify exactly what has changed in their speech and voice. The study team will choose ECT as it is one of the most effective and rapid treatment for depression. The study team will use a service provided by a company, NeuroLex, who has complex computer programs (artificial intelligence, AI) to analyze the voice samples.
Primary Outcome
crossings per second
Interventions
- OTHER Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-11-07 |
| Est. Completion | 2021-02-17 |
What the finished NCT04420793 record still lists
NCT04420793 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT04420793 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04420793 about?
NCT04420793 is a clinical study titled "Voice Changes During ECT". Depressed patients talk differently when they are depressed compared to when they are well. But it is hard to actually measure what the differences are. The study team will record voice samples from patients with mood disturbances, like depression, over the course of their receiving an electroconvul...
What is the current status of trial NCT04420793?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2019-11-07. Estimated completion is 2021-02-17.
What interventions are being tested in trial NCT04420793?
The interventions under investigation include: Questionnaire (OTHER).
Who is sponsoring clinical trial NCT04420793?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI